Cornelia Schuster

463 total citations
22 papers, 315 citations indexed

About

Cornelia Schuster is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Cornelia Schuster has authored 22 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 8 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Cornelia Schuster's work include Cancer Immunotherapy and Biomarkers (8 papers), Diabetes and associated disorders (6 papers) and CAR-T cell therapy research (5 papers). Cornelia Schuster is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Diabetes and associated disorders (6 papers) and CAR-T cell therapy research (5 papers). Cornelia Schuster collaborates with scholars based in Norway, Germany and United States. Cornelia Schuster's co-authors include Oddbjørn Straume, Lars A. Akslen, Stephan Kissler, Anna Ruckdeschel, Kevin Boerner, Kilian Schober, Thomas Serwold, Mi‐Jeong Kim, Fangzhu Zhao and Bernhard O. Boehm and has published in prestigious journals such as Journal of Clinical Oncology, Immunity and PLoS ONE.

In The Last Decade

Cornelia Schuster

21 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cornelia Schuster Norway 9 118 106 99 64 54 22 315
Arun Shastry India 11 94 0.8× 196 1.8× 69 0.7× 45 0.7× 59 1.1× 18 330
Claudia Canasto‐Chibuque United States 10 250 2.1× 122 1.2× 175 1.8× 89 1.4× 50 0.9× 12 508
Jean‐Luc Taupin France 7 128 1.1× 112 1.1× 115 1.2× 48 0.8× 33 0.6× 13 332
Lukas Pawig Netherlands 6 232 2.0× 159 1.5× 194 2.0× 21 0.3× 55 1.0× 6 485
Els Louagie Belgium 6 201 1.7× 230 2.2× 69 0.7× 48 0.8× 133 2.5× 8 494
Frank El Ouriaghli United States 9 153 1.3× 133 1.3× 126 1.3× 64 1.0× 43 0.8× 10 390
Toranoshin Ayada Japan 8 89 0.8× 296 2.8× 127 1.3× 44 0.7× 60 1.1× 11 450
Daniela R. Macció Argentina 9 66 0.6× 185 1.7× 158 1.6× 34 0.5× 59 1.1× 10 373
Jennifer E. Roy United States 5 136 1.2× 213 2.0× 189 1.9× 51 0.8× 39 0.7× 5 492
Michal Vočka Czechia 11 57 0.5× 144 1.4× 141 1.4× 68 1.1× 98 1.8× 56 349

Countries citing papers authored by Cornelia Schuster

Since Specialization
Citations

This map shows the geographic impact of Cornelia Schuster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cornelia Schuster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cornelia Schuster more than expected).

Fields of papers citing papers by Cornelia Schuster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cornelia Schuster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cornelia Schuster. The network helps show where Cornelia Schuster may publish in the future.

Co-authorship network of co-authors of Cornelia Schuster

This figure shows the co-authorship network connecting the top 25 collaborators of Cornelia Schuster. A scholar is included among the top collaborators of Cornelia Schuster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cornelia Schuster. Cornelia Schuster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Schuster, Cornelia, Lars A. Akslen, & Oddbjørn Straume. (2023). β2‐adrenergic receptor expression in patients receiving bevacizumab therapy for metastatic melanoma. Cancer Medicine. 12(17). 17891–17900. 8 indexed citations
4.
Schuster, Cornelia, Badr Kiaf, Anna Ruckdeschel, et al.. (2022). CD5 Controls Gut Immunity by Shaping the Cytokine Profile of Intestinal T Cells. Frontiers in Immunology. 13. 906499–906499. 2 indexed citations
5.
Jacobsen, Kari Dolven, Oddbjørn Straume, Christian Kersten, et al.. (2021). Ipilimumab in a real‐world population: A prospective Phase IV trial with long‐term follow‐up. International Journal of Cancer. 150(1). 100–111. 20 indexed citations
6.
Bachmann, Ingeborg, et al.. (2019). Prognostic value of uPAR expression and angiogenesis in primary and metastatic melanoma. PLoS ONE. 14(1). e0210399–e0210399. 21 indexed citations
7.
Kiaf, Badr, et al.. (2019). The type 1 diabetes candidate gene Dexi does not affect disease risk in the nonobese diabetic mouse model. Genes and Immunity. 21(1). 71–77. 6 indexed citations
8.
Hovland, Randi, Cornelia Schuster, Hanne Puntervoll, et al.. (2019). ctDNA detected by ddPCR reveals changes in tumour load in metastatic malignant melanoma treated with bevacizumab. Scientific Reports. 9(1). 17471–17471. 30 indexed citations
9.
Straume, Oddbjørn, James B. Lorens, Gro Gausdal, Bjørn Tore Gjertsen, & Cornelia Schuster. (2019). A randomized phase Ib/II study of the selective small molecule Axl inhibitor bemcentinib (BGB324) in combination with either dabrafenib/trametinib (D/T) or pembrolizumab in patients with metastatic melanoma. Annals of Oncology. 30. v563–v563. 3 indexed citations
10.
Schuster, Cornelia, et al.. (2018). Preproinsulin Designer Antigens Excluded from Endoplasmic Reticulum Suppressed Diabetes Development in NOD Mice by DNA Vaccination. Molecular Therapy — Methods & Clinical Development. 12. 123–133. 2 indexed citations
11.
Schuster, Cornelia, et al.. (2018). Peripherally induced regulatory T cells contribute to the control of autoimmune diabetes in the NOD mouse model. European Journal of Immunology. 48(7). 1211–1216. 26 indexed citations
12.
Schuster, Cornelia, Lars A. Akslen, Tomasz Stokowy, & Oddbjørn Straume. (2018). Predictive value of angiogenic proteins in patients with metastatic melanoma treated with bevacizumab monotherapy. The Journal of Pathology Clinical Research. 5(1). 53–62. 8 indexed citations
13.
14.
Schuster, Cornelia, et al.. (2016). Exploring the induction of preproinsulin-specific Foxp3+ CD4+ Treg cells that inhibit CD8+ T cell-mediated autoimmune diabetes by DNA vaccination. Scientific Reports. 6(1). 29419–29419. 10 indexed citations
15.
Schuster, Cornelia, Lars A. Akslen, & Oddbjørn Straume. (2016). Expression of Heat Shock Protein 27 in Melanoma Metastases Is Associated with Overall Response to Bevacizumab Monotherapy: Analyses of Predictive Markers in a Clinical Phase II Study. PLoS ONE. 11(5). e0155242–e0155242. 13 indexed citations
16.
Schuster, Cornelia, Kilian Schober, Kevin Boerner, et al.. (2015). The Autoimmunity-Associated Gene CLEC16A Modulates Thymic Epithelial Cell Autophagy and Alters T Cell Selection. Immunity. 42(5). 942–952. 76 indexed citations
17.
Schuster, Cornelia, et al.. (2013). A Missing PD-L1/PD-1 Coinhibition Regulates Diabetes Induction by Preproinsulin-Specific CD8 T-Cells in an Epitope-Specific Manner. PLoS ONE. 8(8). e71746–e71746. 4 indexed citations
18.
Straume, Oddbjørn, Cornelia Schuster, Hanne Puntervoll, et al.. (2012). Abstract 3704: Clinical efficacy and safety of bevacizumab monotherapy in patients with metastatic melanoma: predictive importance of induced early hypertension in a single-arm Phase II study. Cancer Research. 72(8_Supplement). 3704–3704. 1 indexed citations
19.
Schuster, Cornelia, Hans Petter Eikesdal, Hanne Puntervoll, et al.. (2012). Clinical Efficacy and Safety of Bevacizumab Monotherapy in Patients with Metastatic Melanoma: Predictive Importance of Induced Early Hypertension. PLoS ONE. 7(6). e38364–e38364. 41 indexed citations
20.
Petrak, Frank, et al.. (2004). 73-COPING WITH TYPE 1 DIABETES: RESULTS OF THE GERMAN MULTICENTER DIABETES COHORT STUDY.. Journal of Psychosomatic Research. 56(6). 618–618. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arun Shastry Breakdown of academic impact, for papers by Claudia Canasto‐Chibuque Breakdown of academic impact, for papers by Jean‐Luc Taupin Breakdown of academic impact, for papers by Lukas Pawig Breakdown of academic impact, for papers by Els Louagie Breakdown of academic impact, for papers by Frank El Ouriaghli Breakdown of academic impact, for papers by Toranoshin Ayada Breakdown of academic impact, for papers by Daniela R. Macció Breakdown of academic impact, for papers by Jennifer E. Roy Breakdown of academic impact, for papers by Michal Vočka
Rankless by CCL
2026